会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 96. 发明授权
    • Field of modular multifunctional ligands
    • 模块化多功能配体领域
    • US07648843B2
    • 2010-01-19
    • US11775255
    • 2007-07-10
    • Harry Tetsuo UyedaHedi M MattoussiIgor L Medintz
    • Harry Tetsuo UyedaHedi M MattoussiIgor L Medintz
    • G01N33/543G01N33/551G01N33/544C07C321/12C07C321/16
    • B82Y15/00B82Y5/00B82Y10/00G01N33/532G01N33/588Y10T436/182
    • This invention pertains to a surface ligand; preparation of the ligand; colloidal nanoparticle, such as quantum dot bearing one or more of the ligand; and a bioconjugate characterized by a nanoparticle bearing one or more of the ligand conjugated to a biomolecule. The ligand is characterized by the presence of a first module containing atoms that can attach to an inorganic surface; a second module that imparts water-solubility to the ligand and to the inorganic surface that may be attached to the ligand; and a third module that contains a functional group that can, directly or indirectly, conjugate to a biomolecule. Order of the modules can be different and other modules and groups can be on the ligand. Preparation of the ligand includes the steps of reacting a compound having atoms that can attach to an inorganic surface with a water-solubilizing compound that imparts the property of water-solubility to the ligand and the inorganic surface to which it may be attached and purification thereof. Colloidal nanoparticle is characterized by an inorganic surface having attached to it one or more of the ligands. The colloidal bioconjugate is characterized by an inorganic surface having attached thereto one or more of the ligand wherein at least some of the ligand have a biomolecule conjugated thereto.
    • 本发明涉及表面配体; 配体的制备; 胶体纳米颗粒,例如带有一个或多个配体的量子点; 其特征在于具有一个或多个与生物分子缀合的配体的纳米颗粒。 该配体的特征在于存在可以附着到无机表面上的原子的第一模块; 赋予配体和附着于配体的无机表面的水溶性的第二模块; 以及包含可以直接或间接缀合到生物分子的官能团的第三模块。 模块的顺序可以不同,其他模块和组可以在配体上。 配体的制备包括以下步骤:将具有可附着于无机表面的原子的化合物与赋予其可配位的无机表面和赋予其水溶性的水溶性化合物反应 。 胶体纳米颗粒的特征在于其上连接有一个或多个配体的无机表面。 胶体生物缀合物的特征在于其上附着有一种或多种配体的无机表面,其中至少一些配体具有与其缀合的生物分子。
    • 100. 发明授权
    • Naphthyloxyacetic acid derivatives and drugs comprising the same as
active ingredients
    • 萘氧基乙酸衍生物和包含与活性成分相同的药物
    • US6018068A
    • 2000-01-25
    • US102
    • 1998-01-26
    • Yuuki NagaoKazuhiko TorisuNobuyuki Hamanaka
    • Yuuki NagaoKazuhiko TorisuNobuyuki Hamanaka
    • C07C59/68C07C69/712C07C217/60C07C233/18C07C255/16C07C317/18C07C323/16C07D257/04C07C321/12C07C317/00
    • C07D257/04C07C217/60C07C233/18C07C255/16C07C317/18C07C323/16C07C59/68C07C69/712
    • The naphthyloxyacetic acid derivatives of the formula (I) ##STR1## wherein A is H, --(alkylene)COOR.sup.1, --(alkylene)CONR.sup.2 R.sup., --(alkylene)OH, --(alkylene)tetrazole, --(alkylene)CN; E is single bond or alkylene; G is --S--, --SO--, --SO.sub.2 --, --O-- or --NR.sup.4 --; L is alkylene, --(CH.sub.2).sub.m --CH=CH--(CH.sub.2).sub.n -- or --(CH.sub.2).sub.x --CH(OH)--(CH.sub.2).sub.y --; M is phenyl, phenyl(thio, oxy, amino), diphenylmethyl, diphenylmethyl(thio, oxy, amino), and pharmaceutical composition comprising them as an active ingradient. The compounds of the formula (I) can combine PGE.sub.2 receptor and exhibit the activity to antagonize or agonize for PGE.sub.2 receptor. Therefore, they are useful as anti-hyperlipemia, for the prevention of abortion, for analgesics, as antidiarrheals, sleep inducer, diuretic, anti-diabetes, abortient, cathartics, antiulcer, anti-gastritis or antihypertensive etc.
    • PCT No.PCT / JP96 / 01833 Sec。 371日期1998年1月26日 102(e)日期1998年1月26日PCT提交1996年7月2日PCT公布。 公开号WO97 / 05091 日本时间1997年2月13日其中A为H, - (亚烷基)COOR1 - (亚烷基)CONR2R, - (亚烷基)OH, - (亚烷基)四唑, - (亚烷基)CN的式(I)的萘氧基乙酸衍生物 E是单键或亚烷基; G是-S - , - SO - , - SO 2 - , - O-或-NR 4 - ; L是亚烷基, - (CH 2)m -CH = CH-(CH 2)n - 或 - (CH 2)x -CH(OH) - (CH 2)y - M是苯基,苯基(硫代,氧基,氨基),二苯基甲基,二苯基甲基(硫代,氧基,氨基),以及包含它们作为活性成分的药物组合物。 式(I)化合物可以组合PGE 2受体并表现出拮抗或激动PGE2受体的活性。 因此,它们可用作抗高血脂,防止流产,镇痛药,止泻药,睡眠诱导剂,利尿剂,抗糖尿病,止痛药,通气药,抗溃疡药,抗胃炎或抗高血压药等。